Beijing - A Chinese biological company has issued a recall of a batch of its human rabies vaccine over concerns for consumer safety, the State Food and Drug Administration (SFDA) announced.

The vaccine, which was made and released by the Wuhan Institute of Biological Products in Central China's Hubei province under batch number 200905007-3, involved 10,902 doses, of which 8,376 had been used by Monday, the administration said in an online statement on Tuesday.

To date, drug authorities have received no reports of adverse sideeffects associated with the substandard vaccine, the statement said.